Merck's COVID-19 antiviral pill is the second FDA-authorized - TechCrunch

Mercks COVID 19 antiviral pill is the second FDA authorized TechCrunch

There will already be some competition in the US for Pfizer's COVID-19 antiviral pill. As the Attached print reports, the Food and Drug Administration has issued an emergency use permit for Merck’s Molnupiravir pill. The treatment limits the replication of SARS-CoV-2 by inserting "errors" in the genetic code of the virus during infection at a relatively young age, and would be preferable. prevents moderate to severe exacerbations in high-risk patients.

The treatment may not get as much use as Pfizer's Paxlovid, however. Merck's offer will only be available to those 18 years or older versus 12 years for Pfizer, as there are concerns that it could affect bone and cartilage development in younger patients. There are also warnings against using it during pregnancy or while trying to conceive - the FDA has stated that people should use birth control both during and after pregnancy. treatment, with women waiting days and men waiting three months.

Molnupiravir does not appear to be as effective as Paxlovid. While Pfizer's solution reduced hospitalization and mortality by as much as 90 percent, only Merck controlled 30 percent. This pill may be the second choice, especially in cases where Paxlovid is not available. Both companies' products are expected to remain effective against the 'Omicron' virus variants as they do not target altering spike proteins.

However, this could become another useful tool for reducing hospitalization and COVID-19 deaths. Pfizer pill is the easiest to get when the U.S. prescribes enough to treat 10 million patients, but there will be enough Merck drug to treat 3.1 million. Even though the effectiveness is limited, it could save hundreds of thousands of people from the worst of the disease.

READ  House committee scrutinizes January. 6 subpoenas Meta, YouTube, Twitter and Reddit - TechCrunch

Editor's note: This article originally appeared on Engadget.

Related Posts

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Subir

We use cookies to ensure that we give the best user experience on our website. If you continue to use this site we will assume that you agree. More information